Respiratory Motion, Inc.

Respiratory Motion, Inc. focuses on innovative respiratory monitoring solutions that enhance patient care and safety during medical procedures. Their technology aims to improve outcomes in healthcare settings by providing precise respiratory data. Founded in 2010 and headquartered in Watertown, US, Respiratory Motion, Inc.

develops advanced respiratory monitoring systems. The company has engaged in various funding rounds, with the most recent being a Series B round led by Easton Capital Investment Group in July 2022, raising USD 5. 75 mn. As of this funding round, the company has raised a total of USD 5.

75 mn, achieving a current valuation of USD 17. 76 mn. The company has completed 9 deals to date. Alexander Panasyuk is the founder of the firm, while Jenny Freeman and Laura Piccinini serve as CEOs.

Respiratory Motion, Inc. specializes in respiratory monitoring solutions designed to enhance patient safety and clinical efficiency. Their primary product line includes advanced monitoring devices that provide real-time data on patient respiratory status, significantly aiding clinicians in making informed decisions during medical interventions. Respiratory Motion, Inc.

generates revenue through the sale of its respiratory monitoring devices and associated services. Revenue is realized from direct sales to healthcare institutions and ongoing service agreements, which ensure continued engagement and support for their products. Following its acquisition by Senzime AB in July 2022 for USD 44 mn, Respiratory Motion, Inc. aims to expand its product lineup, with new monitoring solutions in development expected to launch in the coming years.

The company plans to penetrate additional healthcare markets in North America and Europe by 2025. The recent funding will be allocated to scaling production capacity, enhancing R&D for new products, and increasing market presence in these targeted regions.